• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Akcea Therapeutics - Articles and news items


Akcea and Ionis’ familial chylomicronaemia syndrome study a success

Industry news / 23 March 2017 / Niamh Marriott, Junior Editor

Akcea Therapeutics’ pivotal Phase 3 study of volanesorsen reduced triglyceride levels in patients with familial chylomicronaemia syndrome…

Cardiovascular risk

Novartis invests in Ionis’ therapies to reduce cardiovascular risk

Industry news / 10 January 2017 / Niamh Marriott, Digital Editor

Novartis announced a collaboration and option agreement to license two novel treatments with the potential to significantly reduce cardiovascular risk…